C. Vivek Lal

Founder & Chief Scientific Officer Alveolus Bio

Seminars

Tuesday 15th September 2026
Inhaled Biotherapeutics: Creating First-in-Class Therapies for COPD
1:00 pm
  • Neutrophilic Inflammation as a therapeutic target in COPD
  • Novel biologics and biotherapeutics for COPD: Exploring first-in-class approaches
  • Particle engineering for distal lung delivery
C. Vivek Lal